Longevity

2 articles

AI algorithms analyzing molecular structures in a futuristic lab, visualizing human rejuvenation and healthspan extension.

AI Accelerates Whole Body Rejuvenation Drug Discovery for Healthspan

David Sinclair plans to launch human tests of an oral 'reprogramming' drug as part of a $101 million XPrize competition, according to MIT Technology Review .

Lena Petrova·June 10, 2026

Advanced laboratory equipment and a visual representation of cellular regeneration, symbolizing a new era in aging research and rejuvenation therapies.

Biotech & Health

David Sinclair's Company Gets FDA Nod for Rejuvenation Trial

Life Biosciences, co-founded by prominent longevity researcher David Sinclair, has received FDA approval to begin the first human trial for a 'rejuvenation treatment' called ER-100.

Lena Petrova·June 9, 2026